表紙
市場調查報告書
商品編碼
996431

醫療行業(RA)全球外包市場的藥品事務申請(2021-2026)

Healthcare Regulatory Affairs Outsourcing Market (2021 - 2026)

出版日期: | 出版商: IndustryARC | 英文 108 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球醫療應用(RA)外包市場預計將在2019年達到24億美元,在2025年達到33.7億美元,在預測期內(2020-)。預計2025年的複合年增長率為7.2% %。市場的主要驅動力是隨著研發(R&D)成本增加和專利到期數量增加而降低成本的需求。

就每種服務而言,監管文件的創建和發佈是最大的部分。按最終用戶而言,製藥公司是最大的需求目的地。按地區劃分,北美國家是最大的市場,並且預計未來會有顯著的市場增長。

本報告分析了全球醫療行業監管文件(RA)的外包市場,並分析了市場的基本結構,主要的促進/限制因素以及總體市場規模趨勢展望,我們將為您提供信息,例如服務類型/最終用戶/地區/主要國家/地區的詳細趨勢,資本交易/業務策略的發展狀況以及主要公司的概況。

目錄

第1章醫療行業(RA)外包市場的藥事申請:概述

第2章醫療行業(RA)外包市場的藥品事務申請:執行摘要

第3章醫藥行業(RA)外包市場的藥品事務申請:比較分析

  • 產品比較:適用於主要公司
  • 財務分析:適用於主要公司
  • 市場份額分析:適用於主要公司
  • 專利分析:適用於主要公司
  • 價格趨勢分析

第4章醫療行業(RA)外包市場的藥品事務申請:啟動方案

  • 主要創業公司分析
    • 投資額
    • 市場收入
    • 風險投資和貸款方案

第5章醫藥行業(RA)外包市場的藥品事務申請:行業市場進入場景

  • 監管框架:概述
  • 新業務開業/業務發展的難易程度指標
  • 案例研究:風險公司的成功故事

第6章醫藥事務在醫療行業(RA)外包市場中的應用影響因素

  • 市場推廣因素
  • 市場抑制因素/問題
  • 波特的五力分析
    • 供應商議價能力
    • 客戶的議價能力
    • 新進入者的威脅
    • 現有公司之間的競爭關係
    • 替代產品威脅

第7章醫藥行業(RA)外包市場的藥事申請:戰略分析

  • 價值鏈分析
  • 市場機會分析
  • 產品生命週期

第8章醫療行業(RA)外包市場的藥品事務申請:按服務類型(基於金額)

  • 臨床試驗申請和產品註冊
  • 法規諮詢,法人代表業務
  • 提交給監管機構
  • 創建和發佈法規文本
  • 其他

第9章醫療行業(RA)外包市場的藥品事務申請:按最終用戶(基於金額)

  • 生物技術公司
  • 醫療器械公司
  • 製藥公司

第10章醫療行業(RA)外包市場的藥品事務申請:按地區(基於金額)

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲國家

第11章醫藥行業(RA)外包市場的藥事申請:市場變化的方向

第12章醫療行業(RA)外包市場的藥品事務申請:行業/行業競爭環境

  • 市場份額分析
    • 全球市場份額:對於主要公司
    • 按地區劃分的市場份額:對於主要公司
    • 國家(地區)的市場份額:對於主要公司
    • 每個公司的最佳做法

第13章醫療行業(RA)外包市場的藥品事務申請:每個國家/地區的主要公司列表

第14章醫療行業(RA)外包市場的藥品事務申請:公司分析

  • Accell Clinical Research, LLC.
  • Charles River Laboratories International, Inc.
  • Clinilabs, Inc
  • Criterium Inc.
  • Covance, Inc.
  • Cardinal Health
  • Freyr
  • ICON PLc.
  • IQVIA
  • Medpace, Inc.
  • PAREXEL International Corporation
  • Pharmaceutical Product Development, (PPD) LLC.
  • Promedica International
  • PRA Health Sciences
  • WuXi App Tec
目錄
Product Code: HCR 75827

Healthcare Regulatory Affairs Outsourcing Market size is valued at $2.40 Bn in 2019, and is estimated to reach $3.37 Bn by 2025, growing at CAGR of 7.2% during the forecast period of 2020-2025. Healthcare regulatory affairs outsourcing are the regulatory policies that are implemented to ensure that companies obey with certain performance standards in relation to their business. These policies aim to protect public health and well-being by ensuring the safety of healthcare and pharmaceutical products. Outsourcing of healthcare regulation includes the medical writing and publication of regulatory documents provided by quality control and experienced medical writers and publishers who play a vital role in developing high-quality documentation for clinical research projects. The global Healthcare Regulatory Affairs Outsourcing Market growth is primarily attributed to the rising number of patent expiration along with growing costs of research and development activities. The service providers have been shifting their focus to outsource healthcare regulatory activities for reducing costs and focusing on core competencies, which helps to increase the growth of the Global Healthcare Regulatory Affairs Outsourcing Market over the forecast years 2020-2025.

Report Coverage

The report: "Healthcare Regulatory Affairs Outsourcing Market Forecast (2020-2025)", by Industry ARC, covers an in-depth analysis of the following segments of the Healthcare Regulatory Affairs Outsourcing Market.

  • By Service Type: Clinical Trial Applications and Product Registrations, Regulatory Consulting and Legal Representation, Regulatory Submissions, Regulatory Writing and Publishing, and others.
  • By End User: Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.
  • By Geography: North America, Europe.

Key Takeaways

  • Geographically, North America dominated the market with a share of 54% in the year 2019 owing to the huge number of R&D activities in the field of drug discovery carried out in the region.
  • The global demand for the Healthcare Regulatory Affairs Outsourcing Market is owing to the rising number of patent expirations around the globe.
  • The prices of the services are not clearly stated, and price fluctuations are estimated to restrain the market growth during the forecast period 2020-2025.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Healthcare Regulatory Affairs Outsourcing Market report.

Healthcare Regulatory Affairs Outsourcing Market Segment Analysis - By Service Type

The global Healthcare Regulatory Affairs Outsourcing Market based on Mode of Service Type, can be further segmented into Clinical Trial Applications and Product Registrations, Regulatory Consulting and Legal Representation, Regulatory Submissions, Regulatory Writing and Publishing, and others. Regulatory Writing and Publishing segment registered for the highest revenue of $865m in 2019 and is estimated to grow at highest CAGR of 7.5% over the forecast years 2020-2025. This is owing to the growing demand for the regulatory writing and publishing services to develop the regulatory filing documents in comprehensive, standard, reliable, and convincing manner, which drives the growth of the segment. However, the increasing need for high-quality documents to support timely drug approvals in developing countries is estimated to boost the demand for the segment over the forecast period 2020-2025.

Healthcare Regulatory Affairs Outsourcing Market Segment Analysis - By End User

The global Healthcare Regulatory Affairs Outsourcing Market based on End User, can be further segmented into Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies. The Pharmaceutical Companies segment registered for highest revenue of $947m in 2019 and projected to grow at the highest CAGR of 6.3% during the forecast period 2020-2025 owing to the increasing need for efficient development and manufacturing of pharmaceutical products, which subsequently increases the adoption of full-time regulatory affairs outsourcing models to minimize the overall manufacturing cost. The Pharmaceutical companies are actively working to improve productivity and efficiency, streamline clinical trials, and meet strict healthcare regulatory outsourcing and quality assurance requirements to keep pace with the high competition, which is driving the segment.

Healthcare Regulatory Affairs Outsourcing Market Segment Analysis - By Geography

The global Healthcare Regulatory Affairs Outsourcing Market based on Geography, can be further segmented into North America, Asia-Pacific, Europe, and Rest of World. North America registered for the highest revenue of $1.30 Bn in 2019 and is set to grow at highest CAGR of 7.7% over the forecast period 2020-2025 owing to the increasing number of R&D activities in the field of drug discovery carried out in the region. It have a large presence of multinational biotech and pharma companies which carry out a large number of clinical trials and also has the well developed and advanced healthcare infrastructure. However, Europe is estimated to outpace all the regions by clocking the highest CAGR of 7.3% during the forecast period 2020-2025 owing to the health care needs and government funding towards research activities. Moreover, many biotech and pharma companies have started outsourcing their drug development services to various countries like Italy, Germany, and France which is further boosting the market growth for healthcare regulatory affairs outsourcing market.

Healthcare Regulatory Affairs Outsourcing Market Drivers

Increasing the number of patent expirations

The global Healthcare Regulatory Affairs Outsourcing industry growth is primarily attributed to the rising number of patent expiration along with growing costs of research and development activities. Biopharmaceutical and healthcare organizations are likely to team up with many outsourcing companies for getting their devices and drugs approved but the approval time of a drug or device is expensive, long time procedure, and is also a documentation centric procedure. So, the service providers have been shifting their focus to outsource healthcare regulatory activities for reducing costs and focusing on core competencies which helps to increase the growth of the Global Healthcare Regulatory Affairs Outsourcing Market over the forecast years 2020-2025.

Healthcare Regulatory Affairs Outsourcing Market Challenges

Fluctuations in Prices

There is an increase in the instances where prices of the services are not clearly stated in the healthcare regulatory affairs outsourcing market, which is acting as a challenge to the market. Besides, the additional costs are said to be involved in the services with the increasing use of technological platforms such as software for the clinical data management, content management, and database & document management. The technological advances no doubt improves the overall process but adds to the total costs as well which are restraining the market growth during the forecast period 2020-2025.

Healthcare Regulatory Affairs Outsourcing Market Industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Healthcare Regulatory Affairs Outsourcing Market. Key companies of this market Accell Clinical Research, LLC, Charles River Laboratories International, Inc, Clinilabs Inc, Criterium Inc, Covance Inc, Cardinal Health, Freyr, ICON PLc, IQVIA, and Medpace, Inc.

Acquisitions/Product Launches:

  • In July 2020, Covance acquired GlobalCare, a global industry leader in patient-centric decentralized clinical trials (DCTs) to flourish the offerings of Covance DCTs into global markets and manage the growing demand for patient-centric trial designs.
  • In April 2019, Cardinal Health has acquired mscripts. This acquisition will enhance the capabilities that company deliver to their customers and strengthen the relationship between healthcare provider's payers, pharmacies and patients.

Table of Contents

1. Healthcare Regulatory Affairs Outsourcing Market- Overview

  • 1.1. Definitions and Scope

2. Healthcare Regulatory Affairs Outsourcing Market- Executive Summary

  • 2.1. Market Revenue, Market Size and Key Trends
  • 2.2. Key trends by Service Type
  • 2.3. Key trends by End User
  • 2.4. Key trends by Geography

3. Healthcare Regulatory Affairs Outsourcing Market- Comparative Analysis

  • 3.1. Product Benchmarking - Key Companies
  • 3.2. Financial Analysis - Key Companies
  • 3.3. Market Value Split by Key Companies
  • 3.4. Patent Analysis - Key Companies
  • 3.5. Pricing Analysis

4. Healthcare Regulatory Affairs Outsourcing Market- Startup Companies Scenario

  • 4.1. Key Startup Company Analysis by
    • 4.1.1. Investment
    • 4.1.2. Revenue
    • 4.1.3. Venture Capital and Funding Scenario

5. Healthcare Regulatory Affairs Outsourcing Market- Industry Market Entry Scenario

  • 5.1. Regulatory Framework Overview
  • 5.2. New Business and Ease of Doing business index
  • 5.3. Case Studies of Successful Ventures

6. Healthcare Regulatory Affairs Outsourcing Market Forces

  • 6.1. Market Drivers
  • 6.2. Market Constraints/Challenges
  • 6.3. Porters five force model
    • 6.3.1. Bargaining power of suppliers
    • 6.3.2. Bargaining powers of customers
    • 6.3.3. Threat of new entrants
    • 6.3.4. Rivalry among existing players
    • 6.3.5. Threat of substitutes

7. Healthcare Regulatory Affairs Outsourcing Market- Strategic Analysis

  • 7.1. Value Chain Analysis
  • 7.2. Opportunities Analysis
  • 7.3. Market Life Cycle

8. Healthcare Regulatory Affairs Outsourcing Market- By Service Type (Market Size -$Million/$Billion)

  • 8.1. Clinical Trial Applications and Product Registrations
  • 8.2. Regulatory Consulting and Legal Representation
  • 8.3. Regulatory Submissions
  • 8.4. Regulatory Writing and Publishing
  • 8.5. Others

9. Healthcare Regulatory Affairs Outsourcing Market- By End User (Market Size -$Million/$Billion)

  • 9.1. Biotechnology Companies
  • 9.2. Medical Device Companies
  • 9.3. Pharmaceutical Companies

10. Healthcare Regulatory Affairs Outsourcing Market- By Geography (Market Size -$Million/$Billion)

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Mexico
  • 10.2. Europe
    • 10.2.1. U.K.
    • 10.2.2. Germany
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe

11. Healthcare Regulatory Affairs Outsourcing Market- Entropy

12. Healthcare Regulatory Affairs Outsourcing Market- Industry/Segment Competition Landscape

  • 12.1. Market Share Analysis
    • 12.1.1. Global Market Share - Key Companies
    • 12.1.2. Market Share by Region - Key companies
    • 12.1.3. Market Share by Countries - Key Companies
    • 12.1.4. Best Practices for Companies

13. Healthcare Regulatory Affairs Outsourcing Market- Key Company List by Country

14. Healthcare Regulatory Affairs Outsourcing Market Company Analysis

  • 14.1. Accell Clinical Research, LLC.
  • 14.2. Charles River Laboratories International, Inc.
  • 14.3. Clinilabs, Inc
  • 14.4. Criterium Inc.
  • 14.5. Covance, Inc.
  • 14.6. Cardinal Health
  • 14.7. Freyr
  • 14.8. ICON PLc.
  • 14.9. IQVIA
  • 14.10. Medpace, Inc.
  • 14.11. PAREXEL International Corporation
  • 14.12. Pharmaceutical Product Development, (PPD) LLC.
  • 14.13. Promedica International
  • 14.14. PRA Health Sciences
  • 14.15. WuXi App Tec

"*Financials for private companies would be provided on a best efforts basis".

LIST OF TABLES

1.Global Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Services Market 2019-2024($M)

  • 1.1. By Services Market 2019-2024($M) - Global Industry Research
    • 1.1.1. Regulatory Writing and Publishing Market 2019-2024($M)
    • 1.1.2. Regulatory Submissions Market 2019-2024($M)
    • 1.1.3. Clinical Trial Applications and Product Registrations Market 2019-2024($M)
    • 1.1.4. Regulatory Consulting and Legal Representation Market 2019-2024($M)

2.Global Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By End User Market 2019-2024($M)

  • 2.1. By End User Market 2019-2024($M) - Global Industry Research
    • 2.1.1. Large Pharmaceutical Companies Market 2019-2024($M)
    • 2.1.2. Mid-Size Pharmaceutical Companies Market 2019-2024($M)
    • 2.1.3. Biotechnology Companies Market 2019-2024($M)
    • 2.1.4. Medical Devices Companies Market 2019-2024($M)
    • 2.1.5. Food Beverage Companies Market 2019-2024($M)

3.Global Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Services Market 2019-2024(Volume/Units)

  • 3.1. By Services Market 2019-2024(Volume/Units) - Global Industry Research
    • 3.1.1. Regulatory Writing and Publishing Market 2019-2024(Volume/Units)
    • 3.1.2. Regulatory Submissions Market 2019-2024(Volume/Units)
    • 3.1.3. Clinical Trial Applications and Product Registrations Market 2019-2024(Volume/Units)
    • 3.1.4. Regulatory Consulting and Legal Representation Market 2019-2024(Volume/Units)

4.Global Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By End User Market 2019-2024(Volume/Units)

  • 4.1. By End User Market 2019-2024(Volume/Units) - Global Industry Research
    • 4.1.1. Large Pharmaceutical Companies Market 2019-2024(Volume/Units)
    • 4.1.2. Mid-Size Pharmaceutical Companies Market 2019-2024(Volume/Units)
    • 4.1.3. Biotechnology Companies Market 2019-2024(Volume/Units)
    • 4.1.4. Medical Devices Companies Market 2019-2024(Volume/Units)
    • 4.1.5. Food Beverage Companies Market 2019-2024(Volume/Units)

5.North America Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Services Market 2019-2024($M)

  • 5.1. By Services Market 2019-2024($M) - Regional Industry Research
    • 5.1.1. Regulatory Writing and Publishing Market 2019-2024($M)
    • 5.1.2. Regulatory Submissions Market 2019-2024($M)
    • 5.1.3. Clinical Trial Applications and Product Registrations Market 2019-2024($M)
    • 5.1.4. Regulatory Consulting and Legal Representation Market 2019-2024($M)

6.North America Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By End User Market 2019-2024($M)

  • 6.1. By End User Market 2019-2024($M) - Regional Industry Research
    • 6.1.1. Large Pharmaceutical Companies Market 2019-2024($M)
    • 6.1.2. Mid-Size Pharmaceutical Companies Market 2019-2024($M)
    • 6.1.3. Biotechnology Companies Market 2019-2024($M)
    • 6.1.4. Medical Devices Companies Market 2019-2024($M)
    • 6.1.5. Food Beverage Companies Market 2019-2024($M)

7.South America Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Services Market 2019-2024($M)

  • 7.1. By Services Market 2019-2024($M) - Regional Industry Research
    • 7.1.1. Regulatory Writing and Publishing Market 2019-2024($M)
    • 7.1.2. Regulatory Submissions Market 2019-2024($M)
    • 7.1.3. Clinical Trial Applications and Product Registrations Market 2019-2024($M)
    • 7.1.4. Regulatory Consulting and Legal Representation Market 2019-2024($M)

8.South America Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By End User Market 2019-2024($M)

  • 8.1. By End User Market 2019-2024($M) - Regional Industry Research
    • 8.1.1. Large Pharmaceutical Companies Market 2019-2024($M)
    • 8.1.2. Mid-Size Pharmaceutical Companies Market 2019-2024($M)
    • 8.1.3. Biotechnology Companies Market 2019-2024($M)
    • 8.1.4. Medical Devices Companies Market 2019-2024($M)
    • 8.1.5. Food Beverage Companies Market 2019-2024($M)

9.Europe Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Services Market 2019-2024($M)

  • 9.1. By Services Market 2019-2024($M) - Regional Industry Research
    • 9.1.1. Regulatory Writing and Publishing Market 2019-2024($M)
    • 9.1.2. Regulatory Submissions Market 2019-2024($M)
    • 9.1.3. Clinical Trial Applications and Product Registrations Market 2019-2024($M)
    • 9.1.4. Regulatory Consulting and Legal Representation Market 2019-2024($M)

10.Europe Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By End User Market 2019-2024($M)

  • 10.1. By End User Market 2019-2024($M) - Regional Industry Research
    • 10.1.1. Large Pharmaceutical Companies Market 2019-2024($M)
    • 10.1.2. Mid-Size Pharmaceutical Companies Market 2019-2024($M)
    • 10.1.3. Biotechnology Companies Market 2019-2024($M)
    • 10.1.4. Medical Devices Companies Market 2019-2024($M)
    • 10.1.5. Food Beverage Companies Market 2019-2024($M)

11.APAC Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Services Market 2019-2024($M)

  • 11.1. By Services Market 2019-2024($M) - Regional Industry Research
    • 11.1.1. Regulatory Writing and Publishing Market 2019-2024($M)
    • 11.1.2. Regulatory Submissions Market 2019-2024($M)
    • 11.1.3. Clinical Trial Applications and Product Registrations Market 2019-2024($M)
    • 11.1.4. Regulatory Consulting and Legal Representation Market 2019-2024($M)

12.APAC Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By End User Market 2019-2024($M)

  • 12.1. By End User Market 2019-2024($M) - Regional Industry Research
    • 12.1.1. Large Pharmaceutical Companies Market 2019-2024($M)
    • 12.1.2. Mid-Size Pharmaceutical Companies Market 2019-2024($M)
    • 12.1.3. Biotechnology Companies Market 2019-2024($M)
    • 12.1.4. Medical Devices Companies Market 2019-2024($M)
    • 12.1.5. Food Beverage Companies Market 2019-2024($M)

13.MENA Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Services Market 2019-2024($M)

  • 13.1. By Services Market 2019-2024($M) - Regional Industry Research
    • 13.1.1. Regulatory Writing and Publishing Market 2019-2024($M)
    • 13.1.2. Regulatory Submissions Market 2019-2024($M)
    • 13.1.3. Clinical Trial Applications and Product Registrations Market 2019-2024($M)
    • 13.1.4. Regulatory Consulting and Legal Representation Market 2019-2024($M)

14.MENA Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By End User Market 2019-2024($M)

  • 14.1. By End User Market 2019-2024($M) - Regional Industry Research
    • 14.1.1. Large Pharmaceutical Companies Market 2019-2024($M)
    • 14.1.2. Mid-Size Pharmaceutical Companies Market 2019-2024($M)
    • 14.1.3. Biotechnology Companies Market 2019-2024($M)
    • 14.1.4. Medical Devices Companies Market 2019-2024($M)
    • 14.1.5. Food Beverage Companies Market 2019-2024($M)

LIST OF FIGURES

  • 1. US Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 2. Canada Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 3. Mexico Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 4. Brazil Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 5. Argentina Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 6. Peru Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 7. Colombia Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 8. Chile Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 9. Rest of South America Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 10. UK Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 11. Germany Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 12. France Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 13. Italy Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 14. Spain Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 15. Rest of Europe Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 16. China Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 17. India Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 18. Japan Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 19. South Korea Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 20. South Africa Healthcare Regulatory Affairs Outsourcing Trends Analysis Market Revenue, 2019-2024 ($M)
  • 21. North America Healthcare Regulatory Affairs Outsourcing Trends Analysis By Application
  • 22. South America Healthcare Regulatory Affairs Outsourcing Trends Analysis By Application
  • 23. Europe Healthcare Regulatory Affairs Outsourcing Trends Analysis By Application
  • 24. APAC Healthcare Regulatory Affairs Outsourcing Trends Analysis By Application
  • 25. MENA Healthcare Regulatory Affairs Outsourcing Trends Analysis By Application